Desmoplastic myxoid tumor, SMARCB1-mutant: a case with late recurrence after long-term follow-up

Authors

  • Arnault Tauziède-Espariat Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, Paris, France
  • Mathilde Duchesne Department of Pathology, Dupuytren University Hospital, Limoges, France
  • Aymeric Rouchaud Department of Radiology, Dupuytren University Hospital, Limoges, France
  • Amandine Chabernaud Negrier Department of Radiology, Dupuytren University Hospital, Limoges, France
  • Romain Coudert Department of Radiology, Dupuytren University Hospital, Limoges, France
  • Joseph Benzakoun
  • David Guyon Department of Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France
  • Farah Sassi Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, Paris, France
  • Lauren Hasty Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, Paris, France
  • Alice Métais Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, Paris, France
  • Pascale Varlet Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, Paris, France

DOI:

https://doi.org/10.17879/freeneuropathology-2026-9701

Keywords:

Desmoplastic myxoid tumor, Pineal, SMARCB1, Ultrastructural analysis

Downloads

Published

2026-07-06

How to Cite

Tauziède-Espariat, A., Duchesne, M., Rouchaud, A., Chabernaud Negrier, A., Coudert, R., Benzakoun, J., … Varlet, P. (2026). Desmoplastic myxoid tumor, SMARCB1-mutant: a case with late recurrence after long-term follow-up. Free Neuropathology, 7, 16. https://doi.org/10.17879/freeneuropathology-2026-9701

Issue

Vol. 7 (2026)

Section

Letters

License

Copyright (c) 2026 Arnault Tauziède-Espariat, Mathilde Duchesne, Aymeric Rouchaud, Amandine Chabernaud Negrier, Romain Coudert, Joseph Benzakoun, David Guyon, Farah Sassi, Lauren Hasty, Alice Métais, Pascale Varlet

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Papers are published open access under the Creative Commons BY 4.0 license. This license lets others distribute, remix, adapt, and build upon your work, even commercially, as long as they credit you for the original creation. Data included in the article are made available under the CC0 1.0 Public Domain Dedication waiver, unless otherwise stated, meaning that all copyrights are waived.